German biomedical equipment maker Eppendorf Manufacturing Co. said it plans to ramp up its stem cell bioprocessing research now that it’s won state approvals to conduct infectious disease related research in Enfield.
Ma Sha, Eppendorf’s director of technical applications, said in a statement that the company intends to make induced pluripotent stem cells, which are made through the reprogramming of genes in regular cells using viruses.
Eppendorf is now approved to conduct “biosafety level 2” research, which governs facilities in which staff work with agents that pose moderate hazards to personnel and the environment, according to the U.S. Center for Disease Control and Prevention.
In 2010, Eppendorf announced a $25 million, 130,000-square-foot expansion in Enfield, where it first established a presence in 2004.
